Safety Study of Oral BTA9881 to Treat RSV Infection

NCT00504907 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

63

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Syncytial Virus Infections

Interventions

DRUG: BTA9881
DRUG: Placebo

Sponsor

Biota Scientific Management Pty Ltd